Different disease modifying therapies can increase or decrease Covid-19 severity in Multiple Sclerosis

被引：0

作者：

Sormani, Maria Pia ^{[1
]}

De Rossi, Nicola ^{[2
]}

Schiavetti, Irene ^{[1
]}

Carmisciano, Luca ^{[1
]}

Cordioli, Cinzia ^{[2
]}

Moiola, Lucia ^{[3
]}

Radaelli, Marta ^{[4
,5
]}

Immovilli, Paolo ^{[6
]}

Capobianco, Marco ^{[7
]}

Trojano, Maria ^{[8
]}

Zaratin, Paola ^{[9
]}

Tedeschi, Gioacchino ^{[10
]}

Comi, Giancarlo ^{[11
]}

Battaglia, Mario Alberto ^{[9
]}

Patti, Francesco ^{[12
]}

Salvetti, Marco ^{[13
]}

机构：

[1] Univ Genoa, Dept Hlth Sci, Genoa, Italy

[2] ASST Spedali Civili Brescia, Ctr Sclerosi Multipla, Brescia, Italy

[3] IRCCS Osped San Raffaele, Dept Neurol, Multiple Sclerosis Ctr, Milan, Italy

[4] ASST Papa Giovanni XXIII, Dept Neurol, Bergamo, Italy

[5] ASST Papa Giovanni XXIII, Multiple Sclerosis Ctr, Bergamo, Italy

[6] Osped Guglielmo Saliceto, Multiple Sclerosis Ctr, Piacenza, Italy

[7] Univ Hosp San Luigi, Dept Neurol, Reg Referral Multiple Sclerosis, Orbassano, Italy

[8] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy

[9] Italian Multiple Sclerosis Fdn, Res Dept, Genoa, Italy

[10] Univ Campania, Dept Adv Med & Surg Sci, Naples, Italy

[11] IRCCS Osped San Raffaele, Inst Expt Neurol, Milan, Italy

[12] Univ Catania, Policlin Catania, Ctr Sclerosi Multipla, Catania, Italy

[13] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

2021

引用

页数：5

共 50 条

[1] Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Simpson-Yap, Steve
De Brouwer, Edward
Kalincik, Tomas
Rijke, Nick
Hillert, Jan A.
Walton, Clare
Edan, Gilles
Moreau, Yves
Spelman, Tim
Geys, Lotte
Parciak, Tina
Gautrais, Clement
Lazovski, Nikola
Pirmani, Ashkan
Ardeshirdavanai, Amin
Forsberg, Lars
Glaser, Anna
McBurney, Robert
Schmidt, Hollie
Bergmann, Arnfin B.
Braune, Stefan
Stahmann, Alexander
Middleton, Rodden
Salter, Amber
Fox, Robert J.
van der Walt, Anneke
Butzkueven, Helmut
Alroughani, Raed
Ozakbas, Serkan
Rojas, Juan, I
van der Mei, Ingrid
Nag, Nupur
Ivanov, Rumen
do Olival, Guilherme Sciascia
Dias, Alice Estavo
Magyari, Melinda
Brum, Doralina
Mendes, Maria Fernanda
Alonso, Ricardo N.
Nicholas, Richard S.
Bauer, Johana
Chertcoff, Anibal Sebastian
Zabalza, Anna
Arrambide, Georgina
Fidao, Alexander
Comi, Giancarlo
Peeters, Liesbet
NEUROLOGY, 2021, 97 (19) : E1870 - E1885
[2] Multiple Sclerosis and COVID-19: An Overview on Risk, Severity, and Association With Disease Modifying Therapies
Hollist, Mary
Hollist, Abraham
Au, Katherine
Betts, Colton
Kirmani, Maha
Kirmani, Maaida
Armour, Benjamin
Udeh, Mercy C.
Kirmani, Batool F.
NEUROSCIENCE INSIGHTS, 2024, 19
[3] COVID-19 vaccines and multiple sclerosis disease-modifying therapies
Giovannoni, Gavin
Hawkes, Christopher H.
Lechner-Scott, Jeannette
Levy, Michael
Yeh, E. Ann
Baker, David
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 53
[4] Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era
Ciotti, John R.
Grebenciucova, Elena
Moss, Brandon P.
Newsome, Scott D.
ANNALS OF NEUROLOGY, 2020, 88 (06) : 1062 - 1064
[5] COVID-19 and multiple sclerosis - prevalence and the impact of disease modifying therapies
Kieseier, B.
Rajbhandari, R.
Altincatal, A.
Kim, M.
Berdofe, A.
Radhakrishnan, M.
Jung, E.
Sandrock, A.
De Moor, C.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 102 - 103
[6] COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Anthony T. Reder
Diego Centonze
Maria L. Naylor
Anjali Nagpal
Rajani Rajbhandari
Arman Altincatal
Michelle Kim
Aaron Berdofe
Maha Radhakrishnan
Eunice Jung
Alfred W. Sandrock
Karen Smirnakis
Catrinel Popescu
Carl de Moor
CNS Drugs, 2021, 35 : 317 - 330
[7] COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Reder, Anthony T.
Centonze, Diego
Naylor, Maria L.
Nagpal, Anjali
Rajbhandari, Rajani
Altincatal, Arman
Kim, Michelle
Berdofe, Aaron
Radhakrishnan, Maha
Jung, Eunice
Sandrock, Alfred W.
Smirnakis, Karen
Popescu, Catrinel
de Moor, Carl
CNS DRUGS, 2021, 35 (03) : 317 - 330
[8] COVID-19 pandemic: multiple sclerosis patients under disease-modifying therapies
Berger, T.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 58 - 58
[9] COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
Garjani, Afagh
Middleton, Rodden M.
Hunter, Rachael
Tuite-Dalton, Katherine A.
Coles, Alasdair
Dobson, Ruth
Duddy, Martin
Hughes, Stella
Pearson, Owen R.
Rog, David
Tallantyre, Emma C.
das Nair, Roshan
Nicholas, Richard
Evangelou, Nikos
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
[10] Associations of DMT therapies with COVID-19 severity in multiple sclerosis
Simpson-Yap, Steve
De Brouwer, Edward
Kalincik, Tomas
Rijke, Nick
Hillert, Jan
Walton, Clare
Edan, Gilles
Spelman, Tim
Geyes, Lotte
Parciak, Tina
Gautrais, Clement
Lazovski, Nikola
Pirmani, Ashkan
Ardeshirdavani, Amin
Forsberg, Lars
Glaser, Anna
McBurney, Robert
Schmidt, Hollie
Bergmann, Arnfin
Braune, Stefan
Stahmann, Alexander
Middleton, Rodden
Salter, Amber
Fox, Robert
van der Walt, Anneke
Butzkueven, Helmut
Rojas, Juan
van der Mei, Ingrid
Nag, Nupur
Ivanov, Rumen
do Olival, Guilherme Sciascia
Dias, Alice Estavo
Magyari, Melinda
Brum, Doralina Guimaraes
Mendes, Maria Fernandes
Alonso, Ricardo
Nicholas, Richard
Bauer, Johana
Chertcoff, Anibal
Zabalza, Ana
Arrambide, Georgina
Fidao, Alexander
Comi, Giancarlo
Peeters, Liesbet
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50

← 1 2 3 4 5 →